Correlation Between Morgan Stanley and Chemours

Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and Chemours at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and Chemours into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Morgan Stanley and Chemours Co, you can compare the effects of market volatilities on Morgan Stanley and Chemours and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of Chemours. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and Chemours.

Diversification Opportunities for Morgan Stanley and Chemours

0.43

Correlation Coefficient

Morgan Stanley  Chemours

Very weak diversification

The 3 months correlation between Morgan and Chemours is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley and Chemours Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chemours and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley are associated (or correlated) with Chemours. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chemours has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and Chemours go up and down completely randomly.

Pair Corralation between Morgan Stanley and Chemours

Allowing for the 90-day total investment horizon Morgan Stanley is expected to under-perform the Chemours. But the stock apears to be less risky and, when comparing its historical volatility, Morgan Stanley is 3.28 times less risky than Chemours. The stock trades about -0.23 of its potential returns per unit of risk. The Chemours Co is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest  1,905  in Chemours Co on September 19, 2024 and sell it today you would lose (84.00) from holding Chemours Co or give up 4.41% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Morgan Stanley  vs.  Chemours Co

Morgan Stanley

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Morgan Stanley unveiled solid returns over the last few months and may actually be approaching a breakup point.

Chemours

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Chemours Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Chemours is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Morgan Stanley and Chemours

The main advantage of trading using opposite Morgan Stanley and Chemours positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, Chemours can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will offset losses from the drop in Chemours' long position.

The idea behind Morgan Stanley and Chemours Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.